1.850GBp+32.14%Mkt Cap: 6.49M GBpP/E: —Last update: 2026-05-13
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The compa…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B-0.53
P/S1.59
EV/EBITDA-8.43
EV/Revenue5.58
EPS (TTM)-0.01
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-5.88%
FCF Margin-10.15%
Operating CF-46.00K GBp
CapEx (TTM)97.00K GBp
Net Debt/EBITDA-6.03
Net Debt14.99M GBp
Technical
SMA 501.587 (+16.6%)
SMA 2002.161 (-14.4%)
Beta0.22
S&P 52W Chg24.23%
Avg Vol (30d)312.51K
Avg Vol (10d)489.62K
Technical Indicators
RSI (14)62.4
MACD0.0075
MACD Signal-0.0328
MACD Hist.+0.0404
BB Upper1.773 GBp
BB Middle1.476 GBp
BB Lower1.180 GBp
BB Width40.23%
ATR (14)0.2908 GBp
Vol Ratio (20d)0.81x
52W Range
1.20020% of range4.400
52W High4.400 GBp
52W Low1.200 GBp
Profitability
Gross Margin-2.16%
EBITDA Margin-66.19%
Profit Margin-81.50%
Oper. Margin-54.98%
ROE32.12%
ROA-37.08%
Revenue Growth-28.90%
Earnings Growth—
Balance Sheet
Debt/Equity-1.65
Current Ratio0.13
Quick Ratio0.09
Book Value/Sh-0.0320 GBp
Cash/Share0.0020 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.350.72M
Float221.68M
Insiders18.08%
Institutions24.22%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap6.49M GBp
Enterprise Value20.95M GBp
Revenue (TTM)3.76M GBp
Gross Profit-81.00K GBp
Net Income (TTM)-3.06M GBp
Revenue/Share0.0130 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees32
Last Price1.850 GBp
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—